지속적 신대체요법(CRRT) 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 제품별, 모달리티별, 최종사용자 지역별, 경쟁별(2020-2030년)

Continuous Renal Replacement Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Modality, By End User Region and Competition, 2020-2030F

US $ 4,500 ￦ 6,681,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500 ￦ 8,165,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000 ￦ 11,877,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

한글목차

세계의 지속적 신대체요법(CRRT) 시장은 2024년에 13억 2,000만 달러로 평가되었으며, 2030년까지 CAGR 8.91%로 성장하여 22억 달러에 달할 것으로 예측됩니다.

지속적 신대체요법(CRRT)은 주로 중환자 치료 환경에서 급성 신장 손상이나 심각한 체액 과다 상태를 경험하는 중증 환자에게 사용되는 지속적 체외 혈액 정화 기술입니다. 시장 확대는 기본적으로 전 세계 급성 신장 손상 발생률의 증가, 본질적으로 신장 합병증에 대한 소인이 높은 고령 인구의 증가, CRRT 시스템의 지속적인 기술 발전에 의해 주도되고 있습니다.

시장 개요
예측 기간	2026-2030년
시장 규모 : 2024년	13억 2,000만 달러
시장 규모 : 2030년	22억 달러
CAGR : 2025-2030년	8.91%
가장 빠르게 성장하는 부문	지속적 정맥-정맥식 혈액투석여과(CVVHDF)
최대 시장	북미

주요 시장 촉진요인

세계 지속적 신대체요법(CRRT) 시장은 급성 신장 손상 및 만성 신장 질환의 발생률 증가의 영향을 크게 받고 있습니다. 이러한 질환은 고도의 신장 지원이 필요한 경우가 많아 CRRT의 대상 환자군을 직접적으로 확대하고 있습니다.

주요 시장 과제

지속적 신대체요법(CRRT) 장비 및 일회용 세트와 관련된 막대한 비용은 시장 확대에 큰 장벽이 되고 있습니다. 이러한 재정적 부담은 전 세계 의료 시스템에 직접적인 영향을 미치고 있으며, 특히 예산 제약 하에 운영되는 의료 시스템에서 장비 구매 능력과 지속적인 운영 비용을 제한함으로써 의료 시스템에 직접적인 영향을 미치고 있습니다.

주요 시장 동향

인공지능(AI)의 통합으로 지속적 신대체요법의 정확성과 운영 효율성이 크게 향상되고 있습니다. AI 알고리즘은 방대한 환자 데이터를 분석하여 반응 예측, 체액 균형 최적화, 약물 투여 자동화를 실현합니다. 이를 통해 인적 오류를 최소화하고, 집중치료에서 보다 일관성 있는 개별화된 치료를 지원합니다.

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 지속적 신대체요법(CRRT) 시장 전망

• 시장 규모 및 예측
  • 금액별
• 시장 점유율과 예측
  • 제품별(투석액 및 치환액, 일회용 제품, 혈액여과기, 혈관 연결 세트 및 튜브, 기타 일회용 제품, CRRT 시스템)
  • 모달리티별(지속적 정맥-정맥간 혈액여과(CVVH), 지속적 정맥-정맥간 혈액투석여과(CVVHDF), 지속적 정맥-정맥간 혈액투석(CVVHD), 저속 지속적 한외여과(SCUF))
  • 최종사용자별(병원·클리닉, 외래 수술 시설, 기타)
  • 지역별
  • 기업별(2024)
• 시장 맵

제6장 북미의 지속적 신대체요법(CRRT) 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 지속적 신대체요법(CRRT) 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 지속적 신대체요법(CRRT) 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 중동 및 아프리카의 지속적 신대체요법(CRRT) 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 사우디아라비아
  • 아랍에미리트
  • 남아프리카공화국

제10장 남미의 지속적 신대체요법(CRRT) 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 콜롬비아
  • 아르헨티나

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 인수합병
• 제품 출시
• 최근 동향

제13장 세계의 지속적 신대체요법(CRRT) 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

• 업계내 경쟁
• 신규 참여의 가능성
• 공급업체의 능력
• 고객의 능력
• 대체품의 위협

제15장 경쟁 구도

• Baxter International, Inc
• Fresenius Ag & Co.
• Nikkiso Co., Ltd
• Braun Melsungen Ag
• Medtronic Plc
• Asahi Kasei Corporation
• Toray Medical Co., Ltd.
• Informed SA
• Nipro Corporation
• Medica SPA

제16장 전략적 제안

제17장 조사 회사 소개 및 면책사항

KSM

영문 목차

영문목차

The Global Continuous Renal Replacement Therapy Market, valued at USD 1.32 Billion in 2024, is projected to experience a CAGR of 8.91% to reach USD 2.20 Billion by 2030. Continuous Renal Replacement Therapy (CRRT) represents a continuous extracorporeal blood purification technique employed for critically ill patients experiencing acute kidney injury or severe fluid overload, primarily within intensive care settings. The market's expansion is fundamentally driven by the escalating global incidence of acute kidney injury, the increasing geriatric population which inherently presents a higher predisposition to renal complications, and ongoing technological advancements in CRRT systems.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 1.32 Billion
Market Size 2030	USD 2.20 Billion
CAGR 2025-2030	8.91%
Fastest Growing Segment	Continuous venovenous hemodiafiltration (CVVHDF)
Largest Market	North America

Key Market Drivers

The Global Continuous Renal Replacement Therapy market is significantly influenced by the increasing incidence of acute kidney injury and chronic kidney disease. These conditions frequently necessitate advanced renal support, directly expanding the patient pool eligible for CRRT. The widespread nature of renal ailments is underscored by recent findings, where according to EurekAlert! , in October 2025, reporting on the Global Burden of Disease Study 2023, kidney dysfunction was identified among the top ten risk factors for global health loss in 2023. This pervasive health challenge creates a continuous and growing demand for effective therapeutic interventions like CRRT.

Key Market Challenges

The substantial cost associated with Continuous Renal Replacement Therapy equipment and disposable sets represents a significant impediment to market expansion. This financial burden directly affects healthcare systems globally, particularly those operating under budget constraints, by limiting their capacity for equipment acquisition and sustained operational expenses. According to a study published in *Critical Care Explorations* in June 2023, the daily cost of CRRT was estimated to be approximately $872 from a U. S. healthcare payer perspective, indicating a considerable financial commitment for healthcare facilities.

Key Market Trends

The integration of artificial intelligence (AI) is significantly enhancing the precision and operational efficiency of Continuous Renal Replacement Therapy. AI algorithms can analyze extensive patient data to predict responses, optimize fluid balance, and automate medication dosing, thereby minimizing human error and supporting more consistent, tailored treatments in critical care. Fresenius Medical Care, in October 2023, announced its strategic initiative to develop AI models utilizing anonymized data from over 540,000 dialysis patients. This endeavor is aimed at refining various aspects of dialysis therapies, including the optimization of erythropoietin stimulating agents and iron therapies. Such advancements are critical for transitioning from reactive interventions to proactive, data-driven patient management. While the practical application of AI in CRRT is still developing, research into its potential to enhance CRRT delivery has seen substantial growth in recent years, highlighting its recognized importance within the industry.

Key Market Players

• Baxter International, Inc
• Fresenius Ag & Co.
• Nikkiso Co., Ltd
• Braun Melsungen Ag
• Medtronic Plc
• Asahi Kasei Corporation
• Toray Medical Co., Ltd.
• Informed SA
• Nipro Corporation
• Medica SPA

Report Scope:

In this report, the Global Continuous Renal Replacement Therapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Continuous Renal Replacement Therapy Market, By Product:

• Dialysates and Replacement Fluids
• Disposables
• Hemofilters
• Bloodline Sets & Tubes
• Other Disposables
• CRRT Systems

Continuous Renal Replacement Therapy Market, By Modality:

• Continuous venovenous hemofiltration (CVVH)
• Continuous venovenous hemodiafiltration (CVVHDF)
• Continuous venovenous hemodialysis (CVVHD)
• Slow continuous ultrafiltration (SCUF)

Continuous Renal Replacement Therapy Market, By End User:

• Hospital & Clinics
• Ambulatory Surgical care
• Others

Continuous Renal Replacement Therapy Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Continuous Renal Replacement Therapy Market.

Available Customizations:

Global Continuous Renal Replacement Therapy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Continuous Renal Replacement Therapy Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Dialysates and Replacement Fluids, Disposables, Hemofilters, Bloodline Sets & Tubes, Other Disposables, CRRT Systems)
  • 5.2.2. By Modality (Continuous venovenous hemofiltration (CVVH), Continuous venovenous hemodiafiltration (CVVHDF), Continuous venovenous hemodialysis (CVVHD), Slow continuous ultrafiltration (SCUF))
  • 5.2.3. By End User (Hospital & Clinics, Ambulatory Surgical care, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Continuous Renal Replacement Therapy Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Modality
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Continuous Renal Replacement Therapy Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Modality
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Continuous Renal Replacement Therapy Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Modality
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Continuous Renal Replacement Therapy Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Modality
      • 6.3.3.2.3. By End User

7. Europe Continuous Renal Replacement Therapy Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Modality
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Continuous Renal Replacement Therapy Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Modality
      • 7.3.1.2.3. By End User
  • 7.3.2. France Continuous Renal Replacement Therapy Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Modality
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Continuous Renal Replacement Therapy Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Modality
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Continuous Renal Replacement Therapy Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Modality
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Continuous Renal Replacement Therapy Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Modality
      • 7.3.5.2.3. By End User

8. Asia Pacific Continuous Renal Replacement Therapy Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Modality
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Continuous Renal Replacement Therapy Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Modality
      • 8.3.1.2.3. By End User
  • 8.3.2. India Continuous Renal Replacement Therapy Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Modality
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Continuous Renal Replacement Therapy Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Modality
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Continuous Renal Replacement Therapy Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Modality
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Continuous Renal Replacement Therapy Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Modality
      • 8.3.5.2.3. By End User

9. Middle East & Africa Continuous Renal Replacement Therapy Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Modality
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Continuous Renal Replacement Therapy Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Modality
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Continuous Renal Replacement Therapy Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Modality
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Continuous Renal Replacement Therapy Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Modality
      • 9.3.3.2.3. By End User

10. South America Continuous Renal Replacement Therapy Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Modality
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Continuous Renal Replacement Therapy Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Modality
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Continuous Renal Replacement Therapy Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Modality
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Continuous Renal Replacement Therapy Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Modality
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Continuous Renal Replacement Therapy Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Baxter International, Inc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Fresenius Ag & Co.
• 15.3. Nikkiso Co., Ltd
• 15.4. Braun Melsungen Ag
• 15.5. Medtronic Plc
• 15.6. Asahi Kasei Corporation
• 15.7. Toray Medical Co., Ltd.
• 15.8. Informed SA
• 15.9. Nipro Corporation
• 15.10. Medica SPA

16. Strategic Recommendations

17. About Us & Disclaimer

관련자료